There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Cardiol Therapeutics (CRDL – Research Report), Paragon 28 (FNA – Research Report) and Intra-Cellular Therapies (ITCI – Research Report) with bullish sentiments.
Cardiol Therapeutics (CRDL)
Canaccord Genuity analyst Edward Nash maintained a Buy rating on Cardiol Therapeutics yesterday and set a price target of $6.00. The company’s shares closed last Thursday at $2.04, close to its 52-week high of $2.17.
According to TipRanks.com, Nash is a 3-star analyst with an average return of
Cardiol Therapeutics has an analyst consensus of Moderate Buy, with a price target consensus of $6.00.
See today’s best-performing stocks on TipRanks >>
Paragon 28 (FNA)
Canaccord Genuity analyst Caitlin Cronin maintained a Buy rating on Paragon 28 yesterday and set a price target of $17.00. The company’s shares closed last Thursday at $10.20.
According to TipRanks.com, Cronin is a 2-star analyst with an average return of
Currently, the analyst consensus on Paragon 28 is a Strong Buy with an average price target of $18.00, representing a 51.0% upside. In a report issued on March 28, Needham also reiterated a Buy rating on the stock with a $17.00 price target.
Intra-Cellular Therapies (ITCI)
Canaccord Genuity analyst Sumant Kulkarni maintained a Buy rating on Intra-Cellular Therapies today and set a price target of $100.00. The company’s shares closed last Thursday at $67.21.
According to TipRanks.com, Kulkarni is a 4-star analyst with an average return of
Intra-Cellular Therapies has an analyst consensus of Strong Buy, with a price target consensus of $83.55, implying a 22.0% upside from current levels. In a report issued on April 3, RBC Capital also maintained a Buy rating on the stock with a $86.00 price target.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Read More on CRDL:
